A Clinical Study on Effect of Vyoshadi Guggulu on Patients Having Uterine Fibroids

A Single Arm Prospective Clinical Study on Effect of Vyoshadi Guggulu on Dhatu Pradoshaja Vikaras wsr to Uterine Fibroids - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061394

Enrollment

Registered

2024-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified Health Condition 2: N858- Other specified noninflammatory disorders of uterus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pt having single or multiple Uterine Fibroids of less than 5cms

Exclusion criteria

Exclusion criteria: 1.Patient having fibroid of size more than 5 cm as per USG report. 2.Ovarian tumour, tubo-ovarian mass and malignant tumours along with fibroid. 3.Prediagnosed Cases of Cancer. 4.Patient below the age of 20 years and above the age of 50years. 5.Women with Hb 6.Pregnant women with fibroid.

Design outcomes

Primary

Measure	Time frame
Vyoshadi guggulu is Effective in management of Uterine Fibroids given orally everyday for 3 consecutive mnths assessed every month symptomatically n final outcome after 3 monthsTimepoint: Monthly	—

Secondary

Measure	Time frame
Vyoshadi Guggulu Does not have any role in management of Uterine FibroidsTimepoint: Monthly	—

Countries

India

Contacts

Public ContactDr Iram Bano Mohammed Tarique Sayed

APMs Ayurved Mahavidyalaya, Sion

sujatashrikantjagtap@gmail.com9594162992

Outcome results